High blood sugar can lower risk of one type of brain tumour

Image
IANS New York
Last Updated : Jun 21 2016 | 5:02 PM IST

High blood sugar for long periods can cause serious health problems but surprisingly it can have a protective effect against one type of brain tumour that is not cancerous, says a new study.

"It's so unexpected. Usually diabetes and high blood sugar raises the risk of cancer, and it's the opposite here," said lead researcher Judith Schwartzbaum, Associate Professor at Ohio State University.

The discovery could shed light on the development of meningiomas -- tumours arising from the brain and spinal cord that are usually not cancerous but that can require risky surgery and affect a patient's quality of life.

When the researchers compared blood tests in a group of more than 41,000 Swedes with meningioma diagnoses, they found that high blood sugar, particularly in women, actually meant the person was less likely to face a brain tumour diagnosis.

"It should lead to a better understanding of what's causing these tumors and what can be done to prevent them," Schwartzbaum noted.

Though meningiomas are rarely cancerous, they behave in a similar way, leading scientists to wonder if some relationships between possible risk factors and tumour development would be similar, Schwartzbaum said.

The researchers, looking at data collected from 1985 to 2012, identified 296 cases of meningioma, more than 61 percent of them in women.

Women with the highest fasting blood sugar were less than half as likely as those with the lowest readings to develop a tumour.

The study was published in the British Journal of Cancer.

Possible explanations for the relationship could be found by closer examination of the role of sex hormones and the interplay between glucose levels and those hormones, Schwartzbaum said.

It's also possible that sugar levels dip during early tumour development because the tumour is using glucose to grow, she said.

A diabetes diagnosis before meningioma also appeared to decrease the risk of this tumour, although Schwartzbaum said the data likely had incomplete information on diabetes.

--IANS

vc/gb/dg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 21 2016 | 4:52 PM IST

Next Story